期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
加味升降散治疗青壮年高脂血症疗效研究
1
作者 麦静愔 何青青 温洁 《中国初级卫生保健》 2021年第5期68-70,共3页
目的:观察加味升降散治疗青壮年高脂血症患者的临床疗效。方法:将96例青壮年高脂血症患者,随机分为观察组与对照组,每组各48例。两组均予以常规治疗,观察组予以加味升降散颗粒,对照组加服安慰剂。两组疗程均为3个月,观察两组治疗有效率... 目的:观察加味升降散治疗青壮年高脂血症患者的临床疗效。方法:将96例青壮年高脂血症患者,随机分为观察组与对照组,每组各48例。两组均予以常规治疗,观察组予以加味升降散颗粒,对照组加服安慰剂。两组疗程均为3个月,观察两组治疗有效率,比较血脂、同型半胱氨酸和颈动脉内膜中层厚度的情况。结果:(1)最终完成试验者78例,观察组38例,对照组40例。(2)观察组有效30例,无效8例,有效率为78.9%,而对照组有效19例,无效21例,有效率为47.5%;组间有效率比较差异有统计学意义(P<0.05)。(3)组间治疗后比较,观察组TC、TG、LDL-C和Apo B100水平明显降低,HDL-C、Apo AI水平明显升高,与对照组相比改善明显,差异有统计学意义(P<0.05)。(4)组间治疗后比较,观察组Hcy、IMT的水平均明显降低,与对照组相比差异有统计学意义(P<0.05)。结论:加味升降散治疗青壮年高脂血症患者的临床疗效满意,可明显改善患者脂质代谢,有效降低患者血清Hcy水平,改善IMT厚度,值得临床上进一步推广应用。 展开更多
关键词 加味升降散 高脂血症 同型半胱氨酸 颈动脉内膜中层厚度
下载PDF
陈建杰教授分期论治非酒精性脂肪性肝病的经验报道 被引量:5
2
作者 麦静愔 陈建杰 《中国中西医结合杂志》 CAS CSCD 北大核心 2019年第10期1263-1265,共3页
陈建杰系主任医师、教授,上海市名中医,第六批全国老中医药专家学术经验继承工作指导老师,从医40余载,临证经验颇丰,擅长运用中医中药治疗慢性肝病。笔者有幸师从陈建杰教授,随诊左右,获益匪浅,现将陈建杰教授分期论治非酒精性脂肪性肝... 陈建杰系主任医师、教授,上海市名中医,第六批全国老中医药专家学术经验继承工作指导老师,从医40余载,临证经验颇丰,擅长运用中医中药治疗慢性肝病。笔者有幸师从陈建杰教授,随诊左右,获益匪浅,现将陈建杰教授分期论治非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)的临床经验初步总结如下。 展开更多
关键词 非酒精性脂肪性肝病 分期论治 陈建杰 老中医药专家 中医中药治疗 LIVER 主任医师 学术经验
原文传递
Antifibrotic Effect of Total Flavonoids of Astmgali Radix on Dimethylnitrosamine-lnduced Liver Cirrhosis in Rats 被引量:8
3
作者 CHENG Yang mai jing-yin +2 位作者 WANG Mei-feng CHEN Gao-feng PING Jian 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2017年第1期48-54,共7页
Objective:To study the effect of total flavonoids of Astmgali Radix(TFA)on liver cirrhosis induced with dimethylnitrosamine(DMN)in rats,and the effect on peroxisome proliferator-activated receptorγ(PPARγ),unc... Objective:To study the effect of total flavonoids of Astmgali Radix(TFA)on liver cirrhosis induced with dimethylnitrosamine(DMN)in rats,and the effect on peroxisome proliferator-activated receptorγ(PPARγ),uncoupling protein 2(UCP2)and farnesoid X receptor(FXR).Methods:Fifty-three Sprague-Dawley rats were randomly divided into a control group(10 rats)and a DMN group(43 rats).Rats in the DMN group were given DMN for 4 weeks and divided randomly into a model group(14 rats),a low-dosage TFA group(14 rats)and a high-dosage TFA group(15 rats)in the 3rd week.Rats were given TFA for 4 weeks at the dosage of 15 and 30 mg/kg in the low-and high-TFA groups,respectively.At the end of the experiment blood and liver samples were collected.Serum liver function and liver tissue hydroxyproline content were determined.hematoxylin-eosin(HE),Sirus red and immunohistochemical stainings of collagenⅠ,smooth muscle actin(α-SMA)was conducted in paraffinembedded liver tissue slices.Real time polymerase chain reaction(PCR)was adopted to determine PPARγ,UCP2 and FXR m RNA levels.Western blot was adopted to determine protein levels of collagenⅠ,α-SMA,PPARγ,UCP2 and FXR.Results:Compared with the model group,TFA increased the ratio of liver/body weight(low-TFA group P〈0.05,high-TFA group P〈0.01),improved liver biochemical indices(P〈0.01 for ALT,AST,GGT in both groups,P〈0.05 for albumin and TBil in the high-TFA group)and reduced liver tissue hydroxproline content(P〈0.01 in both groups)in treatment groups significantly.HE staining showed that TFA alleviated liver pathological changes markedly and Sirus red staining showed that TFA reduced collagen deposition,alleviated formation and extent of liver pseudolobule.CollagenⅠandα-SMA immunohistochemical staining showed that staining area and extent markedly decreased in TFA groups compared with the model group.TFA could increase PPARγ,it regulated target UCP2,and FXR levels significantly compared with the model group(in the low-TFA group all P〈0.05,in the high group all P〈0.01).Conclusions:TFA could improve liver function,alleviate liver pathological changes,and reduce collagen deposition and formation of liver pseudolobule in rats with liver cirrhosis.The antifibrotic effect of TFA was through regulating PPARγsignal pathway and the interaction with FXR. 展开更多
关键词 total flavonoids of Astmgali Radix DIMETHYLNITROSAMINE liver cirrhosis peroxisome proliferator-activated receptor γ uncoupling protein 2 farnesoid X receptor RAT
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部